With the results of the FLOW trial anticipated next year, as well as high rates of obesity and CVD in type 1 diabetes, there remains an unmet need for additional mechanistic and CVD/kidney outcome studies of GLP1-RAs in the population with type 1 diabetes and CKD [50]
Recovery from psychotic illness: a 15- and 25-year international follow-up study
Gender differences have emerged as well, with women reporting higher usage rates than men, particularly when weight management is the primary indication
A Guide to FDA-Approved GLP-1 Medications GLP-1 receptor agonists are categorized by their chemical structure, how long they stay active in your body
Clinical RCT 2014 Phase 2b RCT in postoperative ileus (bowel resection inpatients) Beck, Sweeney, and McCarter (Ipamorelin 201 Study Group) reported a multicenter, double-blind, placebo-controlled proof-of-concept study in bowel-resection inpatients
these reactive oxygen species kill pathogens and, in the process, can damage the leukocytes themselves (15)